
Local Anesthesia Drugs Market by Drug Type (Bupivacaine, Chloroprocaine, Lidocaine), Mode of Administration (Injectable, Surface Anesthetic), Distribution Channel, End-Use - Global Forecast 2024-2030
Description
Local Anesthesia Drugs Market by Drug Type (Bupivacaine, Chloroprocaine, Lidocaine), Mode of Administration (Injectable, Surface Anesthetic), Distribution Channel, End-Use - Global Forecast 2024-2030
The Local Anesthesia Drugs Market size was estimated at USD 2.65 billion in 2023 and expected to reach USD 2.80 billion in 2024, at a CAGR 5.47% to reach USD 3.86 billion by 2030.
Local anesthesia drugs are medical substances used to temporarily block the sensation of pain or discomfort in a specific area of the body. These drugs work by inhibiting the nerves' ability to transmit pain signals to the brain. Unlike general anesthetics, which induce a state of unconsciousness, local anesthetics allow patients to remain fully awake and aware during medical procedures, with the targeted area rendered numb to pain. The need for local anesthesia drugs is propelled by factors such as the increasing number of surgeries, advancements in anesthetic drugs, and the growing inclinations towards for minimally invasive procedures. Additionally, improvements in healthcare infrastructure globally and rising dental and cosmetic surgeries contribute significantly to the market expansion. However, major challenges include regulatory compliances, competition from generic drugs, and the need for continuous innovation to address drug resistance can hamper growth. Additionally, reduced efficacy and performance of the drugs and pressure from the development of non-pharmacological pain management technologies may limit the use of local anesthetics. However, key players are focusing on innovation in drug formulation and delivery systems, aiming to enhance efficacy, safety, and patient comfort and research into novel local anesthetics with fewer side effects and longer duration of action has also gained traction. Additionally, integrating digital health technologies for precise drug administration could streamline procedural efficiencies, presenting a competitive edge.
Please Note: PDF & Excel + Online Access - 1 Year
Table of Contents
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rising number of surgeries across the globe
- 5.1.1.2. Increase in approval rate of local anesthesia drugs
- 5.1.1.3. Growing use of local anesthetic for post-operative pain
- 5.1.2. Restraints
- 5.1.2.1. Side effects of anesthetic drugs
- 5.1.3. Opportunities
- 5.1.3.1. Introduction of new and effective drugs
- 5.1.3.2. Increase in R&D activities for development of efficient drug
- 5.1.4. Challenges
- 5.1.4.1. Stringent government regulations
- 5.2. Market Segmentation Analysis
- 5.2.1. Drug Type: Advancements to improve the effectiveness, rapid onset, and versatility in application of lidocaine
- 5.2.2. Mode of Administration: Emerging preference for injectable anesthetics in precise applications
- 5.3. Market Disruption Analysis
- 5.4. Porter’s Five Forces Analysis
- 5.4.1. Threat of New Entrants
- 5.4.2. Threat of Substitutes
- 5.4.3. Bargaining Power of Customers
- 5.4.4. Bargaining Power of Suppliers
- 5.4.5. Industry Rivalry
- 5.5. Value Chain & Critical Path Analysis
- 5.6. Pricing Analysis
- 5.7. Technology Analysis
- 5.8. Patent Analysis
- 5.9. Trade Analysis
- 5.10. Regulatory Framework Analysis
- 6. Local Anesthesia Drugs Market, by Drug Type
- 6.1. Introduction
- 6.2. Bupivacaine
- 6.3. Chloroprocaine
- 6.4. Lidocaine
- 6.5. Mepivacaine
- 6.6. Prilocaine
- 6.7. Ropivacaine
- 7. Local Anesthesia Drugs Market, by Mode of Administration
- 7.1. Introduction
- 7.2. Injectable
- 7.3. Surface Anesthetic
- 8. Local Anesthesia Drugs Market, by Distribution Channel
- 8.1. Introduction
- 8.2. Clinics
- 8.3. Drug Stores/Pharmacies
- 8.4. Hospitals Pharmacies
- 8.5. Online Retailing
- 9. Local Anesthesia Drugs Market, by End-Use
- 9.1. Introduction
- 9.2. Ambulatory Surgical Centers
- 9.3. Dental Clinics
- 9.4. Hospitals
- 9.5. Specialty Clinics
- 10. Americas Local Anesthesia Drugs Market
- 10.1. Introduction
- 10.2. Argentina
- 10.3. Brazil
- 10.4. Canada
- 10.5. Mexico
- 10.6. United States
- 11. Asia-Pacific Local Anesthesia Drugs Market
- 11.1. Introduction
- 11.2. Australia
- 11.3. China
- 11.4. India
- 11.5. Indonesia
- 11.6. Japan
- 11.7. Malaysia
- 11.8. Philippines
- 11.9. Singapore
- 11.10. South Korea
- 11.11. Taiwan
- 11.12. Thailand
- 11.13. Vietnam
- 12. Europe, Middle East & Africa Local Anesthesia Drugs Market
- 12.1. Introduction
- 12.2. Denmark
- 12.3. Egypt
- 12.4. Finland
- 12.5. France
- 12.6. Germany
- 12.7. Israel
- 12.8. Italy
- 12.9. Netherlands
- 12.10. Nigeria
- 12.11. Norway
- 12.12. Poland
- 12.13. Qatar
- 12.14. Russia
- 12.15. Saudi Arabia
- 12.16. South Africa
- 12.17. Spain
- 12.18. Sweden
- 12.19. Switzerland
- 12.20. Turkey
- 12.21. United Arab Emirates
- 12.22. United Kingdom
- 13. Competitive Landscape
- 13.1. Market Share Analysis, 2023
- 13.2. FPNV Positioning Matrix, 2023
- 13.3. Competitive Scenario Analysis
- 13.3.1. Heron Therapeutics Announces Partnership with CrossLink Life Sciences to Expand Promotional Effort for ZYNRELEF, the First and Only Non-Opioid Dual Acting Local Anesthetic for Post-Operative Pain
- 13.3.2. Scilex Holding Company Announces Issuance of New Patent in the U.S. for Its Lead Commercial Product ZTlido (lidocaine topical system) for a Method of Relieving Pain Through the Application of a Lidocaine-Containing Patch
- 13.3.3. Sintetica US Launches Lidocaine Hydrochloride Injection, USP 1%, 2% and 4%
- 13.4. Strategy Analysis & Recommendation
- 14. Competitive Portfolio
- 14.1. Key Company Profiles
- 14.2. Key Product Portfolio
- FIGURE 1. LOCAL ANESTHESIA DRUGS MARKET RESEARCH PROCESS
- FIGURE 2. LOCAL ANESTHESIA DRUGS MARKET SIZE, 2023 VS 2030
- FIGURE 3. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. LOCAL ANESTHESIA DRUGS MARKET DYNAMICS
- FIGURE 7. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
- FIGURE 8. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2023 VS 2030 (%)
- FIGURE 10. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
- FIGURE 12. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
- FIGURE 14. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. UNITED STATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 18. UNITED STATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. EUROPE, MIDDLE EAST & AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 22. EUROPE, MIDDLE EAST & AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 23. LOCAL ANESTHESIA DRUGS MARKET SHARE, BY KEY PLAYER, 2023
- FIGURE 24. LOCAL ANESTHESIA DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
Pricing
Currency Rates